Position in AGEN
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$90,233
+$88,437 QoQ
Shares Held
29,488
+5381.0% QoQ
Ownership
0.065%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#35
of 103 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 26%
Shared 0%
None 74%
Common Shares in AGEN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RHUMBLINE ADVISERS holds $1,404,724,682 across 329 Biotechnology names. AGEN ranks #282 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
396,380 | $196,893,837 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,794 | $98,390,870 | |
| 3 | MRNA |
Moderna, Inc.
|
809,853 | $56,714,005 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
165,579 | $49,844,246 | |
| 5 | INCY |
Incyte Corp
|
428,533 | $48,578,500 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
226,008 | $42,326,778 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
1,178,789 | $41,717,342 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
163,018 | $39,282,447 |
All Filings in AGEN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $90,233 | 29,488 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $1,796 | 538 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $1,689 | 538 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $2,071 | 538 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $2,458 | 538 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $44,469 | 29,450 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $83,827 | 30,594 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $167,929 | 30,644 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $540,237 | 32,253 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $317,041 | 546,623 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $433,940 | 522,820 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $564,088 | 499,193 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $789,780 | 493,613 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $611,806 | 402,504 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $899,567 | 374,820 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $727,423 | 354,841 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $612,804 | 315,879 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $543,568 | 220,963 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $667,728 | 207,369 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $1,092,677 | 208,129 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,100,042 | 200,372 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $497,365 | 182,855 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $621,244 | 195,360 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $709,651 | 177,413 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $784,773 | 199,688 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $338,286 | 138,076 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||